Elaine Ullian - Net Worth and Insider Trading
Elaine Ullian Net Worth
The estimated net worth of Elaine Ullian is at least $10 Million dollars as of 2024-04-26. Elaine Ullian is the Director of Thermo Fisher Scientific Inc and owns about 10,109 shares of Thermo Fisher Scientific Inc (TMO) stock worth over $6 Million. Elaine Ullian is the Director of Vertex Pharmaceuticals Inc and owns about 5,265 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $2 Million. Elaine Ullian is also the Director of Hologic Inc and owns about 27,302 shares of Hologic Inc (HOLX) stock worth over $2 Million. Details can be seen in Elaine Ullian's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Elaine Ullian has not made any transactions after 2017-11-13 and currently still holds the listed stock(s).
Transaction Summary of Elaine Ullian
Elaine Ullian Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Elaine Ullian owns 3 companies in total, including Vertex Pharmaceuticals Inc (VRTX) , Thermo Fisher Scientific Inc (TMO) , and Hologic Inc (HOLX) .
Click here to see the complete history of Elaine Ullian’s form 4 insider trades.
Insider Ownership Summary of Elaine Ullian
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2015-12-01 | director |
| TMO | Thermo Fisher Scientific Inc | 2013-05-07 | director |
| HOLX | Hologic Inc | 2017-11-13 | director |
Elaine Ullian Latest Holdings Summary
Elaine Ullian currently owns a total of 3 stocks. Among these stocks, Elaine Ullian owns 10,109 shares of Thermo Fisher Scientific Inc (TMO) as of May 7, 2013, with a value of $6 Million and a weighting of 58.11%. Elaine Ullian owns 5,265 shares of Vertex Pharmaceuticals Inc (VRTX) as of December 1, 2015, with a value of $2 Million and a weighting of 21.02%. Elaine Ullian also owns 27,302 shares of Hologic Inc (HOLX) as of November 13, 2017, with a value of $2 Million and a weighting of 20.88%.
Latest Holdings of Elaine Ullian
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific Inc | 2013-05-07 | 10,109 | 574.50 | 5,807,621 |
| VRTX | Vertex Pharmaceuticals Inc | 2015-12-01 | 5,265 | 398.96 | 2,100,498 |
| HOLX | Hologic Inc | 2017-11-13 | 27,302 | 76.43 | 2,086,692 |
Holding Weightings of Elaine Ullian
Elaine Ullian Form 4 Trading Tracker
According to the SEC Form 4 filings, Elaine Ullian has made a total of 0 transactions in Thermo Fisher Scientific Inc (TMO) over the past 5 years. The most-recent trade in Thermo Fisher Scientific Inc is the sale of 8,000 shares on May 7, 2013, which brought Elaine Ullian around $661,840.
According to the SEC Form 4 filings, Elaine Ullian has made a total of 0 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 22,500 shares on December 1, 2015, which brought Elaine Ullian around $3 Million.
According to the SEC Form 4 filings, Elaine Ullian has made a total of 0 transactions in Hologic Inc (HOLX) over the past 5 years. The most-recent trade in Hologic Inc is the sale of 9,282 shares on November 13, 2017, which brought Elaine Ullian around $375,921.
Insider Trading History of Elaine Ullian
- 1
Elaine Ullian Trading Performance
GuruFocus tracks the stock performance after each of Elaine Ullian's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Elaine Ullian is 31.44%. GuruFocus also compares Elaine Ullian's trading performance to market benchmark return within the same time period. The performance of stocks bought by Elaine Ullian within 3 months outperforms 6 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Elaine Ullian's insider trading performs compared to the benchmark.
Performance of Elaine Ullian
Average Return
61.59%
Outperforming Transactions
86%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.81 | 31.44 | 43.76 | 61.59 | 35.36 | 24.82 |
| Relative Return to S&P 500(%) | -10.08 | 28.38 | 46.08 | 89.07 | 42 | 22.89 |
Elaine Ullian Ownership Network
Ownership Network List of Elaine Ullian
Ownership Network Relation of Elaine Ullian
Elaine Ullian Owned Company Details
What does Vertex Pharmaceuticals Inc do?
Who are the key executives at Vertex Pharmaceuticals Inc?
Elaine Ullian is the director of Vertex Pharmaceuticals Inc. Other key executives at Vertex Pharmaceuticals Inc include SVP & Chief Accounting Officer Kristen Ambrose , EVP & Chief Technical Ops. Off. Atkinson Edward Morrow Iii , and EVP & Global Research and CSO David Altshuler .
Vertex Pharmaceuticals Inc (VRTX) Insider Trades Summary
Over the past 18 months, Elaine Ullian made no insider transaction in Vertex Pharmaceuticals Inc (VRTX). Other recent insider transactions involving Vertex Pharmaceuticals Inc (VRTX) include a net sale of 32,309 shares made by David Altshuler , a net sale of 53,744 shares made by Stuart A Arbuckle , and a net sale of 11,187 shares made by Ourania Tatsis .
In summary, during the past 3 months, insiders sold 66,939 shares of Vertex Pharmaceuticals Inc (VRTX) in total and bought 0 shares, with a net sale of 66,939 shares. During the past 18 months, 380,077 shares of Vertex Pharmaceuticals Inc (VRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 380,077 shares.
Vertex Pharmaceuticals Inc (VRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vertex Pharmaceuticals Inc Insider Transactions
Elaine Ullian Mailing Address
Above is the net worth, insider trading, and ownership report for Elaine Ullian. You might contact Elaine Ullian via mailing address: C/o Hologic, Inc., Bedford Ma 01730.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
